Novel 'After Minoxidil' Spray Improves Topical Minoxidil Compliance and Hair Style Manageability

This abstract describes androgenetic alopecia, a common dermatological condition, and does not provide new clinical findings.

This study reports a case of pustular allergic contact dermatitis following the use of 5% minoxidil solution in a female patient, highlighting an uncommon reaction to a frequently used dermatological treatment.

This case report details two women with female pattern hair loss who experienced severe scalp allergic contact dermatitis from minoxidil, one due to the active ingredient and the other due to the vehicle.

This study found that topical rosemary solution was as effective as Minoxidil 2% in treating alopecia areata on the scalp.

This review discusses various treatments for alopecia areata, highlighting their limitations and individualized approach, and reports no new clinical results.

In this study, researchers found that dermoscopy does not provide distinguishing features for diagnosing scalp contact dermatitis from topical minoxidil compared to other causes of severe scalp itching.

This review discusses current and emerging drug therapies for treating androgenetic alopecia and alopecia areata, and reports no clinical results; it highlights a need for improved and novel treatments.

This article reviews a case of impressive hair regrowth in a man with androgenetic alopecia using a combination of topical minoxidil and tretinoin, but provides no clinical trial results; the authors call for informed consent before recommending this treatment.

This study observed that allergic contact dermatitis is frequently associated with the use of topical minoxidil for hair loss, suggesting that patch tests could help identify sensitized patients.

In this study, 67 patients developed contact dermatitis from using minoxidil for hair loss, with patch tests suggesting it is a frequent sensitizer among topical drugs.